Total Annual Cost Associated with Best Supportive Care of Patients with Unresectable Advanced Non-Small-Cell Lung Cancer Under Real-World-Conditions in Relation to Results of International Studies.

The available information about BSC for patients with NSCLC of the four published studies result in annual therapy costs per patient of 17,365 – 50,882 € with median costs of 29,261 €. Due to specific characteristics of the different international health care systems, the cost calculation for some kinds of treatments had to be adjusted to fit into the german reimbursement system. In addition, the analysis of the GermanOncology database shows that in Germany, most treatments referring to BSC are provided on an outpatient basis. This leads to significantly lower annual costs than in other international health care systems. Cost factor Calculated annual costs per patient (mean) Calculated annual costs per patient (percentage)